Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region
- 1Department of Healthcare Transformation Initiatives, Center for Population Health Management & Quality, The University of Texas Health Science Center at Houston, Houston
- 2Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center, Houston, Texas
Abstract
Importance: Longitudinal evidence of cervical cancer screening (CCS) trends before and after COVID-19 across demographic cohorts remains limited.
Objective: To examine CCS rates by race and ethnicity, age, language, and census region among patients with at least 1 health care encounter in an electronic medical record (EMR) system from 2019 through 2024, and to evaluate longitudinal trends across these groups.
Design, Setting, and Participants: Using an EMR database, this cross-sectional study evaluated CCS rates among female patients aged 21 to 64 years between 2019 and 2024, stratified by race and ethnicity, age, language, and census region.
Exposures: Race and ethnicity, age, language, and census region.
Main Outcomes and Measures: Descriptive statistics were used to summarize annual CCS rates across demographic groups. The Cochran-Armitage test assessed linear trends over time.
Results: Annual sample sizes ranged from approximately 9 to 16 million patients and increased steadily over time; analytic population sizes varied across subgroups. Most patients were non-Hispanic White, aged 30 to 49 years, English-speaking, and resided in either the South or Northeast. Non-Hispanic White patients had the highest annual CCS rates from 2019 to 2021 but experienced the smallest percentage increase, from 10.98% (95% CI, 10.96%-11.01%) to 13.85% (95% CI, 13.82%-13.87%), over the study period. Hispanic patients experienced the largest percentage increase in CCS rates, from 9.85% (95% CI, 9.80%-9.90%) to 15.51% (95% CI, 15.47%-15.55%). American Indian, Alaska Native, Native Hawaiian, and Pacific Islander patients had the lowest screening rates throughout the study period. Patients aged 30 to 49 years and non–English-speaking patients consistently had the highest CCS rates across all years. Patients in the Western and Southern census regions had lower CCS rates than those in other regions.
Conclusions and Relevance: In this cross-sectional study of patients with at least 1 health care encounter in an EMR system, all CCS rates increased across all racial and ethnic groups from 2019 to 2024, with the greatest gains observed among Hispanic patients. However, persistent disparities remained, particularly among American Indian, Alaska Native, Native Hawaiian, and Pacific Islander patients and those in the Western and Southern regions. These findings suggest that although screening uptake has improved over time, substantial geographic and racial and ethnic disparities in CCS persist, highlighting important areas for future research and intervention efforts.
Related
- Healthcare access, cervical cancer screening, and urogenital health among masculine-presenting people assigned female at birth in Thailand: The HAFFU Project
- Perceived barriers and facilitators influencing cervical and breast cancer screening among healthcare professionals in the Cape Coast Metropolis, Ghana: An explanatory mixed-methods study
- Facilitating HPV DNA test-based screening for cervical cancer in public health settings of India: learnings from the Amethi project
- Understanding cervical cancer screening disparities among Somali women in Southeast Minnesota: a community-engaged mixed methods study
- Assessing an educational strategy to improve community health provider-led provision of cervical cancer screening services in western Kenya: A secondary analysis of the Elimisha-HPV cluster-randomized controlled trial
BibTeX
@article{xie2026cervical,
title = {{Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region}},
author = {Yunbo Xie and Linh Nguyen and Yen-Chi Le and Abigail Zamorano},
journal = {JAMA network open},
year = {2026},
month = oct,
doi = {10.1001/jamanetworkopen.2026.39938},
url = {https://europepmc.org/article/PMC/PMC13675824},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region
AU - Yunbo Xie
AU - Linh Nguyen
AU - Yen-Chi Le
AU - Abigail Zamorano
PY - 2026
DA - 2026/10/01
JO - JAMA network open
DO - 10.1001/jamanetworkopen.2026.39938
UR - https://europepmc.org/article/PMC/PMC13675824
AB - Importance: Longitudinal evidence of cervical cancer screening (CCS) trends before and after COVID-19 across demographic cohorts remains limited. Objective: To examine CCS rates by race and ethnicity, age, language, and census region among patients with at least 1 health care encounter in an electronic medical record (EMR) system from 2019 through 2024, and to evaluate longitudinal trends across these groups. Design, Setting, and Participants: Using an EMR database, this cross-sectional study evaluated CCS rates among female patients aged 21 to 64 years between 2019 and 2024, stratified by race and ethnicity, age, language, and census region. Exposures: Race and ethnicity, age, language, and census region. Main Outcomes and Measures: Descriptive statistics were used to summarize annual CCS rates across demographic groups. The Cochran-Armitage test assessed linear trends over time. Results: Annual sample sizes ranged from approximately 9 to 16 million patients and increased steadily over time; analytic population sizes varied across subgroups. Most patients were non-Hispanic White, aged 30 to 49 years, English-speaking, and resided in either the South or Northeast. Non-Hispanic White patients had the highest annual CCS rates from 2019 to 2021 but experienced the smallest percentage increase, from 10.98% (95% CI, 10.96%-11.01%) to 13.85% (95% CI, 13.82%-13.87%), over the study period. Hispanic patients experienced the largest percentage increase in CCS rates, from 9.85% (95% CI, 9.80%-9.90%) to 15.51% (95% CI, 15.47%-15.55%). American Indian, Alaska Native, Native Hawaiian, and Pacific Islander patients had the lowest screening rates throughout the study period. Patients aged 30 to 49 years and non–English-speaking patients consistently had the highest CCS rates across all years. Patients in the Western and Southern census regions had lower CCS rates than those in other regions. Conclusions and Relevance: In this cross-sectional study of patients with at least 1 health care encounter in an EMR system, all CCS rates increased across all racial and ethnic groups from 2019 to 2024, with the greatest gains observed among Hispanic patients. However, persistent disparities remained, particularly among American Indian, Alaska Native, Native Hawaiian, and Pacific Islander patients and those in the Western and Southern regions. These findings suggest that although screening uptake has improved over time, substantial geographic and racial and ethnic disparities in CCS persist, highlighting important areas for future research and intervention efforts.
SN - 2574-3805
ER -